Abstract:P . vivax malaria is a major global health burden hindering social and economic development throughout many tropical and sub-tropical countries. Pre-erythrocytic (PE) vaccines emerge as an attractive approach for the control and elimination of malaria infection. Therefore, evaluating the magnitude, longevity and prevalence of naturally acquired IgG antibody responses against PE candidate antigens is useful for vaccine design. The antigenicity of five recombinant PE antigens (PvCSP-VK210, PvSSP3, PvM2-MAEBL, PvCelTOS and PvSPECT1) was evaluated in plasma samples from individuals residing in low transmission areas in Thailand (Ranong and Chumphon Provinces). The samples were collected at the time of acute vivax malaria and 90, 270 and 360 days later. The prevalence, magnitude and longevity of total IgG and IgG subclasses were determined for each antigen using the longitudinal data. Our results showed that seropositivity of all tested PE antigens was detected during infection in at least some subjects; anti-PvCSP-VK210 and anti-PvCelTOS antibodies were the most frequent. Titers of these antibodies declined during the year of follow up, but notably seropositivity persisted. Among seropositive subjects at post-infection, high number of subjects possessed antibodies against PvCSP-VK210. Anti-PvSSP3 antibody responses had the longest half-life. IgG subclass profiling showed that the predominant subclasses were IgG1 and IgG3 (cytophilic antibodies), tending to remain detectable for at least 360 days after infection. The present study demonstrated the magnitude and longevity of serological responses to multiple PE antigens of P . vivax after natural infection. This knowledge could contribute to the design of an effective P . vivax vaccine. The main objective of pre-erythrocytic (PE) vaccine development against Plasmodium vivax is to inhibit hepatocyte infection and the development of the hepatic parasite, thus limiting the subsequent invasion of red blood cells. Although immunization with irradiated sporozoites induces immune responses against the circumsporozoite protein (CSP), PE vaccines based on recombinant or synthetic CSP alone have not generated protective immunity. Investigating immune responses to sporozoite proteins which play a key role in PE development could help improve vaccine design strategies. Here, we assessed the prevalence, magnitude and longevity of antibody responses against several PE proteins in vivax malaria patients living in an area of low malaria transmission in Southern Thailand. This study provides evidence that antibody responses to surface, micronemal and traversal proteins of sporozoites developed during acute infection. Although the magnitude of IgG responses to all tested PE antigens declined with time, seropositivity to these antigens was maintained after infection. Future studies demonstrating functional activity of naturally-acquired antibodies against sporozoite invasion of hepatocytes would be invaluable to our understanding of anti-PE immunity and vaccine development.

Plasma-derived extracellular vesicles from Plasmodium vivax patients signal spleen fibroblasts via NF-kB facilitating parasite cytoadherence

Plasmodium vivax spleen-dependent protein 1 and its role in extracellular vesicles-mediated intrasplenic infections

Mass Spectrometry Identification of Biomarkers in Extracellular Vesicles From Plasmodium vivax Liver Hypnozoite Infections

Increased Circulation Time of Plasmodium Falciparum Underlies Persistent Asymptomatic Infection in the Dry Season

Histamine releasing factor and elongation factor 1 alpha secreted via malaria parasites extracellular vesicles promote immune evasion by inhibiting specific T cell responses

Dendritic cell responses to Plasmodium falciparum in a malaria-endemic setting

128A Whole-Blood Transcriptional Signature Predicts Parasite Control and Protection from Malaria Fever During Natural Plasmodium Falciparum Infection

Identification of the Recombinant Plasmodium vivax Surface-Related Antigen as a Possible Immune Evasion Factor Against Human Splenic Fibroblasts by Targeting ITGB1

Extracellular vesicles in malaria: Pathogenesis, diagnosis and therapy

Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax

A systematic analysis of the human immune response to Plasmodium vivax

Dynamics of IgM and IgG Antibody Response Profile against Linear B-Cell Epitopes from Exoerythrocytic (CelTOS and TRAP) and Erythrocytic (CyRPA) Phases of Plasmodium vivax: Follow-Up Study

Exploring the naturally acquired response to Pvs47 gametocyte antigen

The role of the peritrophic matrix and red blood cell concentration in Plasmodium vivax infection of Anopheles aquasalis

Extracellular Vesicles in Malaria: Shedding Light on Pathogenic Depths

Distinct brain and lung endothelial miRNA/mRNA profiles after exposure to Plasmodium falciparum- infected red blood cells

Comparative transcriptomics reveal differential gene expression among Plasmodium vivax geographical isolates and implications on erythrocyte invasion mechanisms

Longitudinal analysis of antibody responses to Plasmodium vivax sporozoite antigens following natural infection

Functional and immunological mapping of domains of the reticulocyte binding protein, Plasmodium vivax PvRBP2a

Profiling the antibody response of humans protected by immunization with Plasmodium vivax radiation-attenuated sporozoites

Plasmodium falciparum erythrocyte membrane protein 1 variants induce cell swelling and disrupt the blood–brain barrier in cerebral malaria